Aditi Bawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aditi Bawa has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Hanan Omer
Internal Medicine, Gujranwala Medical College, Gujranwala, PAK
2 shared publications - Aleesha Kainat
Internal Medicine, University of Pittsburgh Medical Center Health System, McKeesport, Pennsylvania, USA
1 shared publication Anjana C. Pillai
Internal Medicine, University of Pittsburgh Medical Center (UPMC) McKeesport, Pittsburgh, USA
1 shared publicationFarooq Ashraf
Internal Medicine, Gujranwala Medical College, Gujranwala, PAK
1 shared publication- Haseeb Raza
Internal Medicine, Gujranwala Medical College, Gujranwala, PAK
1 shared publication - Junaid Khawaja
Internal Medicine, University of Pittsburgh Medical Center (UPMC) McKeesport, Pittsburgh, USA
1 shared publication
Latest Publications
- Open Access
- 17 July 2022
- Published by Springer Nature in Cureus
- Vol. 14 (7) , e26938
Fusobacterium Bacteremia Causing Hepatic Abscess in a Patient With Diverticulitis
Fusobacterium, a gram-negative non-spore-forming anaerobe, is a common inhabitant of the oral cavity; however, it is not typically found in other organ systems. The occurrence of a hepatic abscess associated with this organism is rare. We present a patient with recurrent diverticulitis with left upper quadrant abdominal pain, and abdominal imaging revealed a hepatic abscess in addition to sigmoid diverticulitis. Further investigations led to an unusual culprit; Fusobacterium nucleatum.
- 17 July 2022
- Published by Springer Nature in Cureus
- Vol. 14 (7) , e26938
Open AccessFusobacterium Bacteremia Causing Hepatic Abscess in a Patient With Diverticulitis
Fusobacterium, a gram-negative non-spore-forming anaerobe, is a common inhabitant of the oral cavity; however, it is not typically found in other organ systems. The occurrence of a hepatic abscess associated with this organism is rare. We present a patient with recurrent diverticulitis with left upper quadrant abdominal pain, and abdominal imaging revealed a hepatic abscess in addition to sigmoid diverticulitis. Further investigations led to an unusual culprit; Fusobacterium nucleatum.
- Open Access
- 10 May 2022
- Published by Springer Nature in Cureus
- Vol. 14 (5) , e24873
COVID-19 Infection Presenting as an Isolated Severe Acute Liver Failure
The clinical features of severe acute respiratory syndrome-coronavirus disease 2019 (SARS-COVID-19) infection range from mild upper respiratory symptoms to severe acute respiratory failure. Among other less common features are diarrhea, nausea, vomiting, elevated liver enzymes, and acute kidney injury. We present a case of a 49-year-old female with no preexisting liver disease who presented with weakness and dizziness for one week. Initial investigations revealed acute liver failure (ALF) and positive COVID-19 on polymerase chain reaction (PCR) testing. The patient did not have any upper or lower respiratory symptoms, and extensive workup to look for other etiologies of acute liver failure was unremarkable. She eventually deteriorated to decompensated liver failure and was transitioned to comfort measures only. Liver injury is a well-documented phenomenon associated with COVID-19 infection. Some of the common pathophysiological mechanisms include direct liver injury, immune-mediated liver damage due to the severe inflammatory response, ischemic injury, endothelial disruption, and coagulopathy. Our case uniquely highlights that SARS-COVID-19 infection may have the potential to solely affect hepatocytes without the classic severe acute respiratory distress syndrome. This case demonstrates that a diagnosis of COVID-19 may be considered if no other etiology of ALF is identified.
- 10 May 2022
- Published by Springer Nature in Cureus
- Vol. 14 (5) , e24873
Open AccessCOVID-19 Infection Presenting as an Isolated Severe Acute Liver Failure
The clinical features of severe acute respiratory syndrome-coronavirus disease 2019 (SARS-COVID-19) infection range from mild upper respiratory symptoms to severe acute respiratory failure. Among other less common features are diarrhea, nausea, vomiting, elevated liver enzymes, and acute kidney injury. We present a case of a 49-year-old female with no preexisting liver disease who presented with weakness and dizziness for one week. Initial investigations revealed acute liver failure (ALF) and positive COVID-19 on polymerase chain reaction (PCR) testing. The patient did not have any upper or lower respiratory symptoms, and extensive workup to look for other etiologies of acute liver failure was unremarkable. She eventually deteriorated to decompensated liver failure and was transitioned to comfort measures only. Liver injury is a well-documented phenomenon associated with COVID-19 infection. Some of the common pathophysiological mechanisms include direct liver injury, immune-mediated liver damage due to the severe inflammatory response, ischemic injury, endothelial disruption, and coagulopathy. Our case uniquely highlights that SARS-COVID-19 infection may have the potential to solely affect hepatocytes without the classic severe acute respiratory distress syndrome. This case demonstrates that a diagnosis of COVID-19 may be considered if no other etiology of ALF is identified.